Inventor · disambiguated record
Chin-Ho Chen
Also filed as: CHEN CHIN-HO
13 granted patents·11 pending applications·50 citations·filing 1993–2025
89Inventor score
Top patents by PatentIndex Score
24 records- 0184US2024366576A1Inhibitors of intracellular invasionMEHARRY MEDICAL COLLEGE·Filed 2024·Application pending·0 cites
- 0282US7026305B2Anti-HIV agents with dual sites of actionMEHARRY MEDICAL COLLEGE·Filed 2003·Granted Apr 11, 2006·17 cites·29 claims
- 0377US12053460B2Inhibitors of intracellular invasionMEHARRY MEDICAL COLLEGE·Filed 2021·Granted Aug 6, 2024·0 cites·12 claims
- 0473US7381717B2Anti-HIV agents with dual sites of actionMEHARRY MEDICAL COLLEGE·Filed 2006·Granted Jun 3, 2008·2 cites·15 claims
- 0572US11123333B2Inhibitors of intracellular invasionMEHARRY MEDICAL COLLEGE·Filed 2019·Granted Sep 21, 2021·0 cites·18 claims
- 0669US7282521B2Anti-retroviral moronic acid derivativesUNIV DUKE·Filed 2005·Granted Oct 16, 2007·1 cites·9 claims
- 0767US9340492B2Meta-Diarylaniline or meta-diarylpyridinamine compound, preparation method and medical uses thereofINST PHARM & TOXICOLOGY AMMS·Filed 2013·Granted May 17, 2016·1 cites·13 claims
- 0866US2024415805A1Compositions and methods of treating invasive pathogensMEHARRY MEDICAL COLLEGE·Filed 2024·Application pending·0 cites
- 0964US2025186499A1Use of a purified exosome dry powder for relieving inflammation or injuryLIN DAO LUNG·Filed 2024·Application pending·0 cites
- 1064US2025186500A1Use of a purified platelet-derived exosome dry powder for relieving inflammation or injuryLIN DAO LUNG·Filed 2024·Application pending·0 cites
- 1162US7988974B2Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrierUNIV DUKE·Filed 2005·Granted Aug 2, 2011·0 cites·6 claims
- 1261US2011275146A1Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aidsUNIV DUKE·Filed 2011·Application pending·0 cites
- 1352US5627023ASuppressor of HIV replication and transcriptionUNIV DUKE·Filed 1993·Granted May 6, 1997·18 cites·5 claims
- 1452US2024218323A1Platelets-containing composition and preparation process thereofLIN DAO LUNG·Filed 2023·Application pending·0 cites
- 1547US2011152229A1Betulinic acid derivatives as anti-hiv agentsUNIV DUKE·Filed 2007·Application pending·0 cites
- 1647US2023404923A1Use of a growth factors-enriched dry powder for relieving inflammation or injurySPIRIT SCIENT CO LTD·Filed 2023·Application pending·0 cites
- 1744US12059495B2Use of a platelet dry powder for relieving inflammation or injury in a portion of respiratory tract (or the airway)SPIRIT SCIENT CO LTD·Filed 2022·Granted Aug 13, 2024·0 cites·19 claims
- 1843US5861490ASuppressor of HIV replication and transcriptionUNIV DUKE·Filed 1995·Granted Jan 19, 1999·5 cites·4 claims
- 1942US2012312470A1Rigid Panel Adhesion Method and a Smearing Module Utilized TherebyCHEN CHIN-HO·Filed 2012·Application pending·0 cites
- 2038US2025295697A1Pharmaceutical composition comprising platelet-derived extracellular vesicles of different sizes activated by freeze-thaw cycles, preparation process thereof, and use in promoting wound healing of respiratory tract-related tissues and alleviating inflammationLIN DAO LUNG STEVEN·Filed 2025·Application pending·0 cites
- 2136US6586174B1Suppressor of HIV-1 replication and transcriptionUNIV DUKE·Filed 1999·Granted Jul 1, 2003·2 cites·1 claims
- 2236US5814519ASupressor of HIV-1 replication and transcriptionDUKE UNIVERSITY MDEICAL CENTER·Filed 1995·Granted Sep 29, 1998·4 cites·7 claims
- 2330US5994054AcDNA cloning methods for the identification of a CD8+ T-lymphocytes suppressor factor capable of inhibiting HIV-1 replicationUNIV DUKE·Filed 1995·Granted Nov 30, 1999·0 cites·5 claims
- 2430US2012101098A13,28-disubstituted betulinic acid derivatives as anti-hiv agentsLEE KUO-HSIUNG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chin-Ho Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →